Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone

Cancer Journal from Scientific American

Volumn 3, Issue 3, 1997, Pages 180-183

  Hesketh, Paul J ^a   Gandara, David R ^b   Hesketh, Ann M ^a   Edelman, Martin ^b   Webber, Lauri M ^a   McManus, Matthew ^a   Hainsworth, John D ^c  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SARAH CANNON RESEARCH INSTITUTE   (United States)

Author keywords

5 hydroxytryptamine receptor antagonists; Antiemetics; cisplatin; dexamethasone; granisetron; prochlorperazine

Indexed keywords

CISPLATIN; DEXAMETHASONE; DOPAMINE RECEPTOR BLOCKING AGENT; ETOPOSIDE; FLUOROURACIL; GRANISETRON; PROCHLORPERAZINE; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; AKATHISIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; FEMALE; GASTROINTESTINAL CARCINOMA; HEAD AND NECK CARCINOMA; HEADACHE; HICCUP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESTLESSNESS; VERTIGO; VOMITING;

ACUTE DISEASE; ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CISPLATIN; DEXAMETHASONE; DRUG EVALUATION; DRUG THERAPY, COMBINATION; FEMALE; GRANISETRON; HUMANS; MALE; MIDDLE AGED; NAUSEA; PROCHLORPERAZINE; TREATMENT OUTCOME; VOMITING;

EID: 0030953660     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Grunberg SM, Hesketh PJ. Control of chemotherapy-induced emesis. N Engl J Med 1993;329:1790-1796.
2. DelFavero A, Roila F, Tonato M. Reducing chemotherapy-induced nausea and vomiting; current perspectives and future possibilities. Drug Safety 1993;9:410-428.
3. Roila F, Tonato M, Ballatori E et al. Comparative studies of various antiemetic regimens. Supportive Care in Cancer 1996;4:270-280.
4. Smith DB, Newlands ES, Rustin GJS et al. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 1991;338:487-490.
5. Smyth JF, Coleman RE, Nicolson M et al. Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? BMJ 1991;303:1423-1426.
6. Hesketh PJ, Harvey WH, Harker WG et al. A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis. J Clin Oncol 1994;12:596-600.
7. Herrstedt J, Sigsgaard T, Boesgaard M et al. Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy. N Engl J Med 1993; 328:1076-1080.
8. 2 antagonist metopimazine (MPZ) in patients receiving platinum-based chemotherapy [abstract]. Proceedings of ASCO 1994;13:443.
9. Gralla RJ, Clark RA, Kris MG et al. Methodology in antiemetic trials. Eur J Cancer 1991;27[suppl 1]:5-8.
10. Kris MG, Gralla RJ, Clark RA et al. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. Cancer Treatment Reports 1985;69:1257-1262.
11. DelFavero A, Roila F, Basurto C et al. Assessment of nausea. Eur J Clin Pharmacol 1990;38:115-120.
12. Diem K, ed. Scientific Tables. Basle, Switzerland: Documenta Geigy, 1973.
13. Kris MG, Gralla RJ, Clark RA et al. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 1985;3:1379-1384.
14. Gandara DR, Harvey WH, Monaghan GG et al. The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo. Semin Oncol 1992;19[suppl 10]:67-71.
15. Latreille J, Laberge F, Stewart D et al. Preventing nausea and vomiting during days 2-7 following high dose cisplatin chemotherapy: a study by the National Cancer Institute of Canada Clinical Trials Group [abstract]. Proceedings of ASCO 1995;14:529.
16. Navari RM, Madajewicz S, Anderson N et al. Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multi-center, double-blind, randomized comparative trial of ondansetron versus placebo. J Clin Oncol 1995;13:2408-2416.
17. Hesketh PJ. Management of cisplatin-induced delayed emesis. Oncology 1996;53[suppl 1]:73-77.
18. Kris MG, Pendergrass KB, Navari RM et al. Prevention of acute emesis following high-dose cisplatin with the combination of oral dolasetron and dexamethasone [abstract]. Supportive Care in Cancer 1996;4:250.